Efficacy of 12 weeks oral beta-alanine supplementation in patients with chronic obstructive pulmonary disease: a double-blind, randomized, placebo-controlled trial.
- 2022-08-17
- RCT · n = 40
- Journal of cachexia, sarcopenia and muscle 13(5)
- Jana De Brandt
- Wim Derave
- Frank Vandenabeele
- Pascal Pomiès
- Laura Blancquaert
- Charly Keytsman
- Marina S Barusso-Grüninger
- Fabiano F de Lima
- Maurice Hayot
- Martijn A Spruit
- Chris Burtin
- PubMed: 35977911
- DOI: 10.1002/jcsm.13048
- High evidence
- Clinical
Beta-alanine supplementation increased muscle carnosine in comparison with PL in patients with COPD (mean difference [95% confidence interval]; +2.82 [1.49-4.14] mmol/kg wet weight; P < 0.001).
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- 3.2 g/day